Search Results - "Strauss, Uwe P."

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Clinical efficacy and safety of regorafenib (REG) in the treatment of metastatic colorectal cancer (mCRC) in daily practice in Germany: Interim results of the prospective multicentre noninterventional RECORA study

    Clinical efficacy and safety of regorafenib (REG) in the treatment of metastatic colorectal cancer (mCRC) in daily practice in Germany: Interim results of the prospective multicentre noninterventional RECORA study by Schulz, Holger, Janssen, Jan, Strauss, Uwe P., Langen, Markus, Frey, Marcel, Fiala-Buskies, Sabine, Bokemeyer, Carsten

    Published in Journal of clinical oncology (01-02-2017)
    “…Abstract only 769 Background: In 2013 REG was approved for mCRC based on the results achieved in the CORRECT trial. However, prospective data from daily…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Clinical efficacy and safety of regorafenib (REG) in the treatment of metastatic colorectal cancer (mCRC) in daily practice in Germany: Final results of the prospective multicentre non-interventional RECORA study

    Clinical efficacy and safety of regorafenib (REG) in the treatment of metastatic colorectal cancer (mCRC) in daily practice in Germany: Final results of the prospective multicentre non-interventional RECORA study by Schulz, Holger, Janssen, Jan, Strauss, Uwe P., Langen, Markus, Dworschak, Kai Uwe, Fiala-Buskies, Sabine, Bokemeyer, Carsten

    Published in Journal of clinical oncology (01-02-2018)
    “…Abstract only 748 Background: In 2013 REG was approved for mCRC based on the results achieved in the CORRECT trial. However, prospective data from daily…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: